B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS

• M Mateos,
• P Hari,
• N Bahlis,
• A Chari,
• NWCJ van de Donk,
• B Dholaria,
• AL Garfall,
• H Goldschmidt,
• KM Kortüm,
• A Krishnan,
• T Martin,
• D Morillo,
• A Oriol,
• D Reece,
• C Rodriguez,
• P Rodríguez-Otero,
• JF San-Miguel,
• SZ Usmani,
• R Verona,
• SXW Lin,
• TJ Prior,
• M Wade,
• B Weiss,
• JD Goldberg,
• E Askari

Affiliations

M Mateos

1 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca (ES)

P Hari

2 Medical College of Wisconsin, Milwaukee (USA)

N Bahlis

3 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary (CA)

A Chari

4 Mount Sinai School of Medicine, New York (USA)

NWCJ van de Donk

5 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam (NL)

B Dholaria

6 Vanderbilt University Medical Center, Nashville (USA)

AL Garfall

7 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (USA)

H Goldschmidt

8 University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases (NCT), Heidelberg (DE)

KM Kortüm

9 University Hospital of Würzburg, Würzburg (DE)

A Krishnan

10 City of Hope Comprehensive Cancer Center, Duarte (USA)

T Martin

11 University of California, San Francisco, San Francisco (USA)

D Morillo

12 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)

A Oriol

13 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona (ES)

D Reece

14 Princess Margaret Cancer Centre, Toronto (CA)

C Rodriguez

15 Wake Forest University School of Medicine, Winston-Salem (USA)

P Rodríguez-Otero

16 Clínica Universidad de Navarra, Navarra (ES)

JF San-Miguel

16 Clínica Universidad de Navarra, Navarra (ES)

SZ Usmani

17 Levine Cancer Institute/Atrium Health, Charlotte (USA)

R Verona

18 Janssen Research & Development, Spring House (USA)

SXW Lin

18 Janssen Research & Development, Spring House (USA)

TJ Prior

18 Janssen Research & Development, Spring House (USA)

M Wade

18 Janssen Research & Development, Spring House (USA)

B Weiss

18 Janssen Research & Development, Spring House (USA)

JD Goldberg

19 Janssen Research & Development, Raritan (USA)

E Askari

12 Hospital Universitario Fundación Jiménez Díaz, Madrid (ES)